Patent details

EP3569619 Title: METHOD OF PRODUCING CD123 SPECIFIC CAR T CELLS FOR CANCER IMMUNOTHERAPY

Basic Information

Publication number:
EP3569619
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP191690023
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHOD OF PRODUCING CD123 SPECIFIC CAR T CELLS FOR CANCER IMMUNOTHERAPY
French Title of Invention:
PROCÉDÉ DE PRODUIRE DES CELLULES RAC T SPÉCIFIQUES DE CD123 POUR UNE IMMUNOTHÉRAPIE DU CANCER
German Title of Invention:
VERFAHREN ZUR HERSTELLUNG CD123-SPEZIFISCHER CAR T ZELLEN FÜR KREBSIMMUNTHERAPIE
SPC Number:

Dates

Filing date:
19/03/2015
Grant date:
26/05/2021
EP Publication Date:
20/11/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/05/2021
EP B1 Publication Date:
26/05/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/03/2022
Expiration date:
19/03/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/05/2021
 
 

Name:
Cellectis
Address:
8 rue de la Croix Jarry, 75013 Paris, France (FR)

Inventor

Name:
GALETTO, Roman
Address:
France (FR)

Priority

Priority Number:
PA201470137
Priority Date:
19/03/2014
Priority Country:
Denmark (DK)

Classification

IPC classification:
C07K 16/28; A61K 39/395; A61P 35/02;

Publication

European Patent Bulletin

Issue number:
202121
Publication date:
26/05/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages